Krystal Biotech Inc (KRYS)

CapEx to Revenue

2.99%

Quarterly · Period ending:

KRYS logo

KRYS CapEx to Revenue

Latest reported2.99%
KRYS Quarterly CapEx/Revenue (0.00% → 2.99%)
High-resolution chart · PNG

KRYS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
2.9902%
6.1432%
1.9971%
1.7423%
1.9825%
7.0354%
0.8789%
1.2476%
1.6092%
2.7845%
4.3827%
20.8158%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
228.4133%
292.7959%
126.9718%
383.4101%
56.6474%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.